TSE:EXE

Extendicare Inc (EXE.TO)

35.31
-0.01 (0.03%)
as of Jun 29, 2026, 8:00:01 pm Market Open.
172 watching
0
Investor Insights
star iconJun 29, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Experts have mixed views on Extendicare Inc. (EXE-T) as it navigates the complexities of the long-term care and home healthcare sectors. Many highlight its strong position to benefit from demographic trends and increased funding from the Ontario government, viewing it as an asset-light play with good margin management. However, some caution about the stock being potentially overvalued given the recent bullish movements in the price, suggesting that much of the positive outlook may already be priced in. The company is noted for its unique corporate structure compared to REITs, but concerns about growth potential and competition from private equity investors are prevalent. Despite its appealing business model and post-pandemic recovery, some experts prefer other stocks in the sector, indicating uncertainty about EXE-T's future growth prospects.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
CSH.UN
DON'T BUY
Model price is around the $7 area. Overvalued.
DON'T BUY
Has been a multi year disappointment. A lot of government regulations. Costs are high.
DON'T BUY
US state legislatures limit their revenues. For demographics, would prefer retirement homes.
BUY
A bit of a value play right now. Has a big asset in some hidden real estate assets. Solid.
WEAK BUY
Bad corporate governance.
DON'T BUY
Growth has not been as great as expected. Demographics for nursing facilities is too far off.
DON'T BUY
Fair market value is $3.
DON'T BUY
Tpp exposed to the swings of the operating income.
WEAK BUY
Prefers Sunrise instead.
BUY
Good story. Has been in and out of this stock several times. At a good price now.
WEAK BUY
Government issues in US could create severe problems.
STRONG BUY
Very profitable. Should continue to turn around
TOP PICK
Have sold some assets to pay down debt. Trades at a discount to its US peers.
BUY
Has undergone a significant turn around. Refocusing from Florida operations into Ontario.
DON'T BUY
Too overleveraged.
Showing 211 to 225 of 237 entries